The renin-angiotensin system in progression, remission and regression of chronic nephropathies

Journal of Hypertension

Volumn 20, Issue SUPPL. 3, 2002, Pages

  Aros, Claudio ^a   Remuzzi, Giuseppe ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Chronic nephropathies; Renal disease progression; Renin angiotensin system blockade

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANGIOTENSIN II; PROTEIN;

CAPILLARY PRESSURE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; GENE CONTROL; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION; HUMAN; INFLAMMATION; KIDNEY FAILURE; KIDNEY FUNCTION; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; CHRONIC DISEASE; DRUG EFFECT; GLOMERULUS; KIDNEY DISEASE; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANGIOTENSIN II; ANIMALS; CHRONIC DISEASE; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; KIDNEY TUBULES; PROTEINS; RENIN-ANGIOTENSIN SYSTEM;

EID: 0036600952     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200212000-00001     Document Type: Conference Paper

References (68)

1. USRDS 1999 Annual Data Report. II. Incidence and prevalence of ESRD
2. Report on management of renal failure in Europe, XXV
3. Remuzzi G Progression, remission, regression of chronic renal diseases
4. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease
5. Role of abnormally high transmural pressure in the permselectivity defect of glomerular capillary wall: A study in early passive Heymann nephritis
6. Tubulointerstitial lesions mediate renal damage in adriamycin glomerulopathy
7. Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis
8. The return of glomerular-filtered albumin to the rat renal vein
9. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein
10. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation
11. Time course and localization of endothelin-1 gene expression in a model of renal disease progression
12. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy
13. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria
14. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation
15. Molecular insights into renal interstitial fibrosis
16. Transforming growth factor-β in tissue fibrosis
17. Angiotensin II receptor antagonists and treatment of hypertension and renal disease
18. Pathophysiology of progressive nephropathies
19. Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney
20. A role for podocytes to counteract capillary wall distension
21. Angiotensin II induces actin polymerization within the glomerular filtration barrier: Possible role in the local regulation of ultrafiltration
22. Angiotensin II depolarizes podocytes in the intact glomerulus of the rat
23. Angiotensin II as a mediator of tubulointerstitial injury
24. Renal tubular hypertrophy induced by angiotensin II
25. Angiotensin II induces alpha3 (IV) collagen expression in cultured urine proximal tubular cells
26. Interstitial pathomechanisms undelying progressive tubulointerstitial damage
27. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade
28. Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules
29. Vasoactive hormones and renal sclerosis
30. Early role of Fsp 1 in epithelial-mesenchymal transformation
31. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes
32. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat
33. Passive Heymann nephritis: Evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury
34. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy
35. The effects of the combination of valsartan (Va), an angiotensin II antagonist, plus benazepril (B), an ACEI, on renal function in the rat remnant kidney model
36. Blood pressure control, proteinuria, and the progression of renal disease
37. Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy
38. Does an adequate control of blood pressure protect the kidney in essential hypertension?
39. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy
40. Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies
41. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
42. Captopril reduces the risk of nephropathy in IDDM patients with microalbuminuria
43. Effects of Ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
44. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial
45. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency: The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group
46. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy
47. Enalapril attenuates increased gene expression of extracellular matrix components in diabetic rats
48. Progression and potential regression of glomerulosclerosis
49. Effective antihypertensive treatment pospones renal insufficiency in diabetic nephropathy
50. Remission of nephrotic syndrome in type 1 diabetes: Long-term follow-up of patients in the Captopril Study
51. In chronic nephropaties prolonged ACE inhibition can induce remission: Dynamics of time-dependent changes in GFR
52. Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril
53. The blunting of the antiproteinuric efficacy of ACE inhibition by high sodium intake can be restored by hydrochlorothiazide
54. Cause of variable therapeutic efficacy of angiotensin converting enzyme inhibitor on glomerular lesions
55. The effect of high dose Candesartan Cilexetil beyond maximal recommended doses in reducing urinary protein excretion
56. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives
57. Antiproteinuric effect of Losartan in patients with chronic renal diseases
58. Remission of nephrotic range albuminuria in diabetic nephropathy
59. Late outcome of a controlled trial of enalapril treatment in progressive chronic renal failure. Hard end-points and infiunce of proteinuria
60. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy
61. Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies
62. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat
63. Therapeutic efficacy of different anti-hypertensive drugs in human diabetic nephropathy: An updated meta-analysis
64. Lipoprotein abnormalities without hypolipidemia in moderate renal insufficiency
65. Effects of lipid reduction on the progression of renal disease: A meta-analysis
66. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function
67. Cigarette smoking and renal function impairment
68. Effect of angiotensin-converting enzyme inhibitors on the progression of non-diabetic renal disease: A meta-analysis of randomized trials